Explore the Site
Home
Latest News
AusBiotech
Events
About
Contact
Subscribe
Search
Follow Us
LinkedIn
Twitter
Instagram
BiotechDispatch
Menu
September 26, 2026
Subscribe
Login
Home
Latest News
AusBiotech
Events
About
Contact
Subscribe
Search
Sign In
Login
Forgot password?
Contact Us
Suite 9214
4 Duff Place
Deakin
ACT
2600
t. 0408 492 937
e.
contact@dailydispatch.com.au
Most Read
Disappointment for Paradigm as Phase 3 knee osteoarthritis trial below continuation threshold
September 23, 2026 - Latest News
Prescient raises $6 million to carry cancer drug PTX-100 past a key dosing decision
September 23, 2026 - Latest News
Actinogen's Alzheimer's pill nears its moment of truth as final trial patient is seen
September 23, 2026
Seven Australian startups share $15.6 million to take on dementia
September 23, 2026 - Latest News
Blood test for eight cancers arrives in Australia with a phased rollout
September 23, 2026
Follow Us
LinkedIn
Twitter
Instagram
New Stories
Disappointment for Paradigm as Phase 3 knee osteoarthritis trial below continuation threshold
September 23, 2026 - - Latest News
Blood test for eight cancers arrives in Australia with a phased rollout
September 23, 2026 -
Prescient raises $6 million to carry cancer drug PTX-100 past a key dosing decision
September 23, 2026 - - Latest News
Seven Australian startups share $15.6 million to take on dementia
September 23, 2026 - - Latest News
Dimerix draws $17 million from loan facility to fund kidney drug trials to completion
September 23, 2026 - - Latest News
Actinogen's Alzheimer's pill nears its moment of truth as final trial patient is seen
September 23, 2026 -
Patrys doses first volunteers in trial of intravenous quetiapine for delirium
September 23, 2026 - - Latest News